Cargando…

Natural Killer Cells Modulation in Hematological Malignancies

Hematological malignancies (HM) treatment improved over the last years resulting in increased achievement of complete or partial remission, but unfortunately high relapse rates are still observed, due to remaining minimal residual disease. Therefore, sustainment of long-term remission is crucial, us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baier, Céline, Fino, Aurore, Sanchez, Carole, Farnault, Laure, Rihet, Pascal, Kahn-Perlès, Brigitte, Costello, Régis T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867693/ https://www.ncbi.nlm.nih.gov/pubmed/24391641 http://dx.doi.org/10.3389/fimmu.2013.00459

Ejemplares similares

Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications
por: Farnault, Laure, et al.
Publicado: (2012)

Revving up Natural Killer Cells and Cytokine-Induced Killer Cells Against Hematological Malignancies
por: Pittari, Gianfranco, et al.
Publicado: (2015)

Effector Functions of Natural Killer Cell Subsets in the Control of Hematological Malignancies
por: Gismondi, Angela, et al.
Publicado: (2015)

Sepsis and neutropenia in hematological malignancies
por: Labiad, Y, et al.
Publicado: (2014)

Expression of activating receptors on natural killer cells from AIDS-related lymphoma patients
por: Mercier-Bataille, Delphine, et al.
Publicado: (2014)

Natural killer cells in non-hematopoietic malignancies
por: Desbois, Mélanie, et al.
Publicado: (2012)

Role of Natural Killer Cells in HIV-Associated Malignancies
por: Leal, Fabio E., et al.
Publicado: (2017)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Natural Killer Cell Immunotherapy: From Bench to Bedside
por: Domogala, Anna, et al.
Publicado: (2015)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies
por: Sahin, Ugur, et al.
Publicado: (2019)

Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review
por: Uppendahl, Locke D., et al.
Publicado: (2018)

Transcription factors involved in the regulation of natural killer cell development and function: an update
por: Luevano, Martha, et al.
Publicado: (2012)

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future
por: Lamb, Margaret G., et al.
Publicado: (2021)

Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
por: Carrega, Paolo, et al.
Publicado: (2017)

Umbilical Cord Blood Natural Killer Cells, Their Characteristics, and Potential Clinical Applications
por: Sarvaria, Anushruti, et al.
Publicado: (2017)

Neoantigens in Hematologic Malignancies
por: Biernacki, Melinda A., et al.
Publicado: (2020)

Effects of 5-azacytidine on natural killer cell activating receptor expression in patients with refractory anemia with excess of blasts
por: Costello, Régis T., et al.
Publicado: (2015)

The Ebola-Glycoprotein Modulates the Function of Natural Killer Cells
por: Edri, Avishay, et al.
Publicado: (2018)

Molecular Mechanisms Directing Migration and Retention of Natural Killer Cells in Human Tissues
por: Castriconi, Roberta, et al.
Publicado: (2018)

Radiotheranostic Agents in Hematological Malignancies
por: Caers, Jo, et al.
Publicado: (2022)

Natural Killer Cells in Asthma
por: Karimi, Khalil, et al.
Publicado: (2013)

Uterine Natural Killer Cells
por: Sojka, Dorothy K., et al.
Publicado: (2019)

Natural Killer Cells in the Lungs
por: Cong, Jingjing, et al.
Publicado: (2019)

The contribution of single-cell analysis of acute leukemia in the therapeutic strategy
por: Madaci, Lamia, et al.
Publicado: (2021)

Impact of Next-Generation Sequencing in Diagnosis, Prognosis and Therapeutic Management of Acute Myeloid Leukemia/Myelodysplastic Neoplasms
por: Madaci, Lamia, et al.
Publicado: (2023)

From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
por: Tabellini, Giovanna, et al.
Publicado: (2019)

Relative expression of receptors in uterine natural killer cells compared to peripheral blood natural killer cells
por: Ismail, Nurul Izza
Publicado: (2023)

Natural Killer Cells and Liver Fibrosis
por: Fasbender, Frank, et al.
Publicado: (2016)

Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)

Unraveling Natural Killer T-Cells Development
por: Bennstein, Sabrina Bianca
Publicado: (2018)

Natural Killer T Cells in Cancer Immunotherapy
por: Nair, Shiny, et al.
Publicado: (2017)

Deciphering Natural Killer Cell Homeostasis
por: Pfefferle, Aline, et al.
Publicado: (2020)

Mechanosensation and Mechanotransduction in Natural Killer Cells
por: Santoni, Giorgio, et al.
Publicado: (2021)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies
por: Barnes, Samantha A., et al.
Publicado: (2021)

Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy
por: Sánchez-Ramón, Silvia, et al.
Publicado: (2016)

Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
por: Kim, Nayoung, et al.
Publicado: (2018)

NCR1 Expression Identifies Canine Natural Killer Cell Subsets with Phenotypic Similarity to Human Natural Killer Cells
por: Foltz, Jennifer A., et al.
Publicado: (2016)

Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions
por: Wang, Zixi, et al.
Publicado: (2020)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rdt5psa8qh5d11v1ltcn3tgiks